2021. Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s20. DOI:https://doi.org/10.25251/skin.5.supp.20.